These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2650305)

  • 1. Production and use of neutralizing monoclonal antibodies to rat interleukin-2.
    Hancock WW; Alberghini TV; Chen-Woan M
    Transplant Proc; 1989 Feb; 21(1 Pt 1):994-6. PubMed ID: 2650305
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment with anti-interleukin-2 receptor monoclonal antibody.
    Strom TB; Gaulton GN; Kelley VE; Diamanstein T; Kupiec-Weglinski J; Tilney NL; Kirkman RL
    Prog Clin Biol Res; 1986; 224():227-38. PubMed ID: 3099309
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of gamma interferon and interleukin-2, and of gamma-interferon antibodies, on the rat immune response against allografts.
    Paineau J; Priestley C; Fabre J; Chevalier S; van der Meide P; Jacques Y; Soulillou JP
    Transplant Proc; 1989 Feb; 21(1 Pt 1):999-1001. PubMed ID: 2495638
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of interleukin-2-producing CD4+ T cells in acute rejection of class I major histocompatibility complex disparate rat heart allografts.
    Ito T; Stepkowski SM; Shirakura R; Nakata S; Yamamoto S; Nozaki S; Miyata M; Matsuda H
    Transplant Proc; 1993 Feb; 25(1 Pt 2):885-7. PubMed ID: 8442257
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-interleukin-2 receptor (IL-2R) antibody against rejection of organ grafts.
    Kupiec-Weglinski JW; Padberg W; Uhteg LC; Towpik E; Lord RH; Ma L; Diamantstein T; Strom TB; Tilney NL
    Transplant Proc; 1987 Feb; 19(1 Pt 1):591-3. PubMed ID: 2978926
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of presensitization with IL-2 receptor antibody plus alloantigen.
    Tyler JD; Wierwille SL; Goldman MH
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1010-2. PubMed ID: 2650062
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanism of action of interleukin-2 receptor (IL-2R) monoclonal antibody (MAb) therapy: target cell depletion or inhibition of function?
    Tellides G; Dallman MJ; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):997-8. PubMed ID: 2650306
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of monoclonal anti-IL-2 antibodies on the survival of rat cardiac allografts.
    Sakagami K; Ohnishi T; Matsuoka J; Ohsaki T; Higaki K; Hanzawa Y; Hamuro J; Orita K
    Transplant Proc; 1987 Feb; 19(1 Pt 1):586-90. PubMed ID: 3547830
    [No Abstract]   [Full Text] [Related]  

  • 9. Interleukin 2 receptor directed therapy in rat recipients of cardiac allografts: synergistic and antagonistic interactions with the gamma interferon network.
    Kupiec-Weglinski JW; van der Meide P; Stunkel KG; Tanaka K; Diamantstein T; Tilney NL
    Transplant Proc; 1989 Feb; 21(1 Pt 1):992-3. PubMed ID: 2495637
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy.
    Mottram PL; Han WR; Purcell LJ; McKenzie IF; Hancock WW
    Transplantation; 1995 Feb; 59(4):559-65. PubMed ID: 7878761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on T lymphocyte activation. II. Monoclonal antibody inhibiting the capacity of rat T lymphoblasts to absorb and to respond to IL-2: an anti-IL-2 receptor antibody?
    Osawa H; Diamantstein T
    Immunology; 1983 Mar; 48(3):617-21. PubMed ID: 6600707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of ICAM-1 and LFA-1 in cardiac allograft rejection of the rat.
    Komori A; Nagata M; Ochiai T; Nakajima K; Hori S; Asano T; Isono K; Tamatani T; Miyasaka M
    Transplant Proc; 1993 Feb; 25(1 Pt 1):831-2. PubMed ID: 8094916
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-CD4 monoclonal antibody-induced allograft survival is associated with a defect in interleukin-2-dependent T-cell activation.
    Pearson TC; Hamano K; Morris PJ; Wood KJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):786-7. PubMed ID: 8438480
    [No Abstract]   [Full Text] [Related]  

  • 15. Attenuation of acute xenograft rejection by short-term treatment with LF15-0195 and monoclonal antibody against CD45RB in a rat-to-mouse cardiac transplantation model.
    Wang H; Hosiawa KA; Garcia B; Shum JB; Dutartre P; Kelvin DJ; Zhong R
    Transplantation; 2003 May; 75(9):1475-81. PubMed ID: 12792500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific acceptance of cardiac allografts after treatment with antibodies to CD80 and CD86 in mice.
    Bashuda H; Seino K; Kano M; Sato K; Azuma M; Yagita H; Okumura K
    Transplant Proc; 1996 Apr; 28(2):1039-41. PubMed ID: 8623220
    [No Abstract]   [Full Text] [Related]  

  • 17. Murine cardiac allograft survival following treatment of recipients with monoclonal anti-L3T4 or Ly-2 antibodies.
    Mottram PL; Wheelahan J; McKenzie IF; Clunie GJ
    Transplant Proc; 1987 Apr; 19(2):2898-901. PubMed ID: 3105127
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel series of low molecular weight immunosuppressive agents.
    Ocain TD; Bastos CM; Gordon KA; Granstein RD; Jenson JC; Jones B; McAuliffe DJ; Newcomb JR
    Transplant Proc; 1996 Dec; 28(6):3032-4. PubMed ID: 8962176
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of CD4 depleting and nondepleting monoclonal antibodies in the mouse heart allograft model.
    Han WR; Mottram PL; McKenzie IF
    Transplant Proc; 1993 Oct; 25(5):2933-4. PubMed ID: 8105591
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-interleukin 2 receptor monoclonal antibody therapy in rat recipients of cardiac allografts: the role of antibody isotype.
    Kupiec-Weglinski JW; Di Stefano R; Stunkel KG; Grutzmann R; Theisen P; Araneda D; Tilney NL; Diamantstein T
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):272-5. PubMed ID: 3126574
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.